美国 · 通讯社与实时数据 · PR Newswire
Samsung Biologics Achieves 'Negligible Risk' Rating in Sustainalytics ESG Assessment
Earns ESG Risk Rating score of 9.0, ranking among the top 0.5% in the pharmaceuticals industry Advances from 'Low Risk' to 'Negligible Risk,' the lowest ESG risk category…
在 PR Newswire 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.prnewswire.com)
